BgASL is a non-profit organization that performs its duty under a written constitution. The association is managed by the BgASL Governing Board
MEMBER OF EASL
English
|
Български
Home page
News
EASL calls on UK Government to tackle the alcohol consumption problem through implementation of the proposed minimum pricing initiative
The National Conference of Bulgarian Society of Gastroenterology and Bulgarian Annual Conference of Liver Diseases
New MEP group aims to raise awareness of growing liver disease epidemic
Governing Board
Main Office
Structure
Constitution
Conferences
Workshop 12-14 April 2013
Consensus Conference
The International Liver Congress™ 2013
Publications
REGIONAL PREVALENCE OF IL28B SNPS RS8099917&RS12979860 IN GENERAL POPULATION AND IN A COHORT OF CHRONIC LIVER DISEASES PATIENTS
PREVALENCE AND CLINCAL SIGNIFICANCE OF OCCULT HEPATITIS B INFECTION IN PATIENTS WITH CHRONIC HEPATITIS C INFECTION
METABOLIC SYNDROME AND SUROGATE MARKERS OF INSULIN RESISTANCE IN NONALCOHOLIC FETTY LIVER DISEASE (NAFLD), CHRONIC HEPATITIS C (CHC) AND B (CHB) IN BULGARIA
DIFFERENCES IN IP-10 LEVELS BETWEEN PATIENTS WITH CHRONIC HBV AND HCV INFECTION
REGIONAL PREVALENCE OF IL28B SNPS RS8099917&RS12979860 IN GENERAL POPULATION AND IN A COHORT OF CHRONIC LIVER DISEASES PATIENTS
CHARACTERISING THE IMMUNE STATUS OF HBV-SPECIFIC CD4+ AND CD8+ T-CELLS PRODUCING IL-17 IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) VIRUS INFECTION
RIBAVIRIN AND RECOMBINANT INTERFERON-a 2B IN PA- TIENTS WllH CHRONIC HCV IN-FECTION NONRESPONDERS OR RELAPSED AFTER MONOTHERAPY WITH INTERFERON-
Practice Guidelines
Practice Guidelines 2015
Practice Guidelines
Home page
|
Publications
Publications and Abstracts
RIBAVIRIN AND RECOMBINANT INTERFERON-a 2B IN PA- TIENTS WllH CHRONIC HCV IN-FECTION NONRESPONDERS OR RELAPSED AFTER MONOTHERAPY WITH INTERFERON-
CHARACTERISING THE IMMUNE STATUS OF HBV-SPECIFIC CD4+ AND CD8+ T-CELLS PRODUCING IL-17 IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) VIRUS INFECTION
REGIONAL PREVALENCE OF IL28B SNPS RS8099917&RS12979860 IN GENERAL POPULATION AND IN A COHORT OF CHRONIC LIVER DISEASES PATIENTS
DIFFERENCES IN IP-10 LEVELS BETWEEN PATIENTS WITH CHRONIC HBV AND HCV INFECTION
METABOLIC SYNDROME AND SUROGATE MARKERS OF INSULIN RESISTANCE IN NONALCOHOLIC FETTY LIVER DISEASE (NAFLD), CHRONIC HEPATITIS C (CHC) AND B (CHB) IN BULGARIA
PREVALENCE AND CLINCAL SIGNIFICANCE OF OCCULT HEPATITIS B INFECTION IN PATIENTS WITH CHRONIC HEPATITIS C INFECTION
REGIONAL PREVALENCE OF IL28B SNPS RS8099917&RS12979860 IN GENERAL POPULATION AND IN A COHORT OF CHRONIC LIVER DISEASES PATIENTS